Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03805360 · ClinicalTrials.gov registry record · Phase 1
The Erector Spinae Plane Block and Its Effect on Respiratory Status and Pain Management in Rib Fracture Patients
A Phase 1 study, sponsored by Virginia Commonwealth University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 4
- Enrollment target
NCT03805360 is a Phase 1 study that was terminated before completion, run by Virginia Commonwealth University. The registered enrollment target is 4 participants.
The verdict
NCT03805360, a Phase 1 study, was terminated before completion, sponsored by Virginia Commonwealth University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this research study is to identify the benefits of a type of nerve block, called an erector spinae plane block (ESP), in the treatment of patients with multiple rib fractures and uncontrolled pain despite receiving current institutional standards of care.
Interventions
- DRUG Ropivacaine
- DRUG Normal Saline Flush, 0.9% Injectable Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2019-05-24 |
| Est. Completion | 2020-01-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03805360
The ClinicalTrials.gov registry entry for NCT03805360 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ropivacaine is the first listed.
NCT03805360 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03805360 about?
NCT03805360 is a clinical study titled "The Erector Spinae Plane Block and Its Effect on Respiratory Status and Pain Management in Rib Fracture Patients". The purpose of this research study is to identify the benefits of a type of nerve block, called an erector spinae plane block (ESP), in the treatment of patients with multiple rib fractures and uncontrolled pain despite receiving current institutional standards of care.
What is the current status of trial NCT03805360?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 4 participants. The study started on 2019-05-24. Estimated completion is 2020-01-10.
What interventions are being tested in trial NCT03805360?
The interventions under investigation include: Ropivacaine (DRUG), Normal Saline Flush, 0.9% Injectable Solution (DRUG).
Who is sponsoring clinical trial NCT03805360?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.